TG Therapeutics TGTX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's net income?
- TG Therapeutics (TGTX) reported net income of $19.78M in Q1 2026.
- How has TG Therapeutics's net income changed year-over-year?
- TG Therapeutics's net income increased by 290.8% year-over-year, from $5.06M to $19.78M.
- What is the long-term trend for TG Therapeutics's net income?
- Over 3 years (2021 to 2025), TG Therapeutics's net income has grown at a 8.7% compound annual growth rate (CAGR), from -$348.1M to $447.18M.
- What does net income mean?
- The company's total accounting profit or loss for the period.
- How do you interpret net income?
- An increase indicates higher profitability, while a decrease suggests declining margins or rising costs.
- How does net income compare across companies?
- Standard across all public companies; peers in the biotech sector often show volatility due to R&D cycles.